{
    "Institution": "Memorial Sloan-Kettering Cancer Center",
    "Publication": {
        "Title": "Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma",
        "URL": "https://doi.org/10.1158/2326-6066.CIR-21-1083",
        "First author": "Maryam Pourmaleki",
        "Date": "2022-03-01"
    },
    "Contact": {
        "Name": "Maryam Pourmaleki",
        "Email": "pourmalm@mskcc.org"
    },
    "Data release": {
        "Repository": "Zenodo (CERN)",
        "URL": "https://doi.org/10.5281/zenodo.4300912",
        "Date": "2022-01-04"
    },
    "Assay": "Multiplexed imaging",
    "Number of specimens measured": 7,
    "Number of cells detected": 700,
    "Number of channels measured": 26,
    "Number of named composite phenotypes pre-specified": 4,
    "Sample cohorts": [
        [
            "1",
            "Before intervention",
            "Response to intralesional IL-2 injection",
            "Extreme responder"
        ],
        [
            "2",
            "Before intervention",
            "Response to intralesional IL-2 injection",
            "Non-responder"
        ],
        [
            "3",
            "After intervention",
            "Response to intralesional IL-2 injection",
            "Non-responder"
        ],
        [
            "4",
            "After intervention",
            "Response to intralesional IL-2 injection",
            "Extreme responder"
        ]
    ]}
